Latest
Most Read
The world's third-richest person says he’s decided to dump all his oil and gas assets. Delivering on that promise will take time
Stocks Rise to Another Record; Oil Up on Cold Snap: Markets Wrap
Tesla to Start Making Cars in India, Targeting Sprawling Market
Bitcoin Retreats After Weekend Rally to Record of Nearly $50,000
U.S. Infection Rate Eases to Lowest Since October: Virus Update
Opinion
Taylor Swift’s Record Label Plays To One Billionaire’s Tune
A listing of Universal Music Group would benefit some investors more than others.
If Your Spouse Smells Wrong, What Do We Learn?
The spread of SARS-CoV-2 has caused an associated pandemic of anosmia, the loss of smell. That could lead to scientific breakthroughs.
Oil Price Targets Would Make a Far Better Goal
There's no easy way to measure supply and demand, making OPEC's efforts to game out a recovery from the pandemic a crapshoot.
Mario Draghi Puts Italy at the Grown-Ups' Table
The ex-ECB chief faces enormous domestic problems, but he could help change Rome’s poor image among the other EU states.
The Big Question: Can France Catch Up in the Covid Vaccine Race?
A Q&A with economist Margaret Kyle on the country’s failure to develop a vaccine and the obstacles standing in the way of French innovation.
Latest
Most Read
Opinion
Taylor Swift’s Record Label Plays To One Billionaire’s Tune
A listing of Universal Music Group would benefit some investors more than others.
If Your Spouse Smells Wrong, What Do We Learn?
The spread of SARS-CoV-2 has caused an associated pandemic of anosmia, the loss of smell. That could lead to scientific breakthroughs.
Oil Price Targets Would Make a Far Better Goal
There's no easy way to measure supply and demand, making OPEC's efforts to game out a recovery from the pandemic a crapshoot.
Mario Draghi Puts Italy at the Grown-Ups' Table
The ex-ECB chief faces enormous domestic problems, but he could help change Rome’s poor image among the other EU states.
The Big Question: Can France Catch Up in the Covid Vaccine Race?
A Q&A with economist Margaret Kyle on the country’s failure to develop a vaccine and the obstacles standing in the way of French innovation.